Durda J, Wedi B, Martin V, Breuer K
Abteilung für Allergologie und Berufsdermatologie, Dermatologikum Hamburg and.
Klinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover, Germany.
Allergol Select. 2017 Aug 4;1(2):222-226. doi: 10.5414/ALX01554E. eCollection 2017.
H antihistamines are important drugs for the treatment of urticaria and are commonly well tolerated. Cases of hypersensitivity reactions to antihistamines have rarely been reported, the underlying pathomechanism is unknown yet.
We report the case of a 28-year-old female patient suffering from chronic spontaneous urticaria who experienced severe episodes of wheals and flares induced by different H antihistamines.
We performed skin prick tests (SPT) with a diversity of H antihistamines and CAST and FlowCAST analyses. Moreover, a placebo controlled oral challenge test to mizolastin was done.
We saw positive SPT reactions to nearly all H antihistamines tested with the exception of mizolastin. We observed neither a release of sulfidoleukotrienes nor an upregulation of basophil activation markers in the CAST and FlowCAST analyses. The oral challenge test with mizolastine resulted in the development of generalized wheals and flares.
H antihistamines are effective drugs for the treatment of urticaria, but they may lead to hypersensitivity reactions in rare cases. Because of the negative CAST and FlowCAST results, an IgE-mediated pathomechanism is improbable. We propose that hypersensitivity reactions to H antihistamines may be induced by a paradox H receptor activation.
H 1 抗组胺药是治疗荨麻疹的重要药物,通常耐受性良好。抗组胺药超敏反应病例鲜有报道,其潜在发病机制尚不清楚。
我们报告一例 28 岁患有慢性自发性荨麻疹的女性患者,她因不同的 H 1 抗组胺药引发严重的风团和潮红发作。
我们用多种 H 1 抗组胺药进行了皮肤点刺试验(SPT)以及嗜碱性粒细胞组胺释放试验(CAST)和流式细胞术嗜碱性粒细胞组胺释放试验(FlowCAST)分析。此外,还对咪唑斯汀进行了安慰剂对照口服激发试验。
除咪唑斯汀外,我们观察到几乎所有受试 H 1 抗组胺药的 SPT 反应均为阳性。在 CAST 和 FlowCAST 分析中,我们既未观察到硫代白三烯的释放,也未观察到嗜碱性粒细胞活化标志物的上调。咪唑斯汀口服激发试验导致全身出现风团和潮红。
H 1 抗组胺药是治疗荨麻疹的有效药物,但在罕见情况下可能会导致超敏反应。由于 CAST 和 FlowCAST 结果为阴性,IgE 介导的发病机制不太可能。我们提出,对 H 1 抗组胺药的超敏反应可能由反常的 H 受体激活所诱发。